India to Mexico Pharmaceutical Export (2026) — $182.0M, 140 Suppliers | TransData Nexus

India to Mexico Pharmaceutical Export (2026) — $182.0M, 140 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Mexico

#	Formulation	Value	Share
1	Mamitra(trastu Inj440mg)withdil.vialslmx	$2.7M	1.5%
2	Sitagliptin / Metformin Hcl 50/850mg	$2.3M	1.2%
3	Atcar 20mg (3x10's) Msn -mx	$1.8M	1.0%
4	Bhava Vialslmx(bevacizumab)	$1.7M	0.9%
5	Sitagliptin 100mg Tablets (2x14's)	$1.6M	0.9%
6	Pharma Drugs and Medi Lesprek 40mg Telmisartan 3x10t As Per Inv	$1.3M	0.7%
7	Immuglo (human Normal Immunoglobulin 5%	$1.2M	0.7%
8	Linagliptina Metformina Tableta 2 5mg 850mg Linagliptin2 5mg Metformin Hydroclo…	$1.2M	0.7%
9	Ykosat 50mg(dasatinib 50mg) (1x60s)	$1.2M	0.7%
10	Ceftriaxone for Injection 1g(auroviax 10	$1.1M	0.6%
11	Compresso Ibu 66	$1.1M	0.6%
12	Paracetamol Granules Dc Grade (acetamino	$1.1M	0.6%
13	Valvey 100iu/ml 10ml Vial Vls	$1.1M	0.6%
14	Fosaprepitant Injection	$1.0M	0.6%
15	Valvey Dispopen 100iu.3ml 5s	$982.8K	0.5%

India exports 20+ pharmaceutical formulations to Mexico with a combined trade value of $182.0M. Key products include Sitagliptin ($2.3M), Bevacizumab ($1.7M), Dasatinib ($1.2M), Ceftriaxone ($1.1M), Paracetamol ($1.1M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 5,454 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Mexico Trade Routes

1Sitagliptin$2.3M 2Bevacizumab$1.7M 3Dasatinib$1.2M 4Ceftriaxone$1.1M 5

Top Indian Exporters to Mexico

1Zydus Lifesciences Limited

$15.8M

2Intas Pharmaceuticals Limited

$14.7M

3Glenmark Pharmaceuticals Limited

$12.9M

4Hetero Labs Limited

$12.4M

Port Analysis — India to Mexico Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR15.8%

DELHI AIR4.7%

HYDERABAD ICD (INSNF6)2.8%

AHEMDABAD AIR ACC (INAMD4)1.9%

NHAVA SHEVA SEA (INNSA1)3.3%

Mexico Import Ports

MEXICO CITY67.7%

Veracruz6.8%

VERACRUZ6.0%

Manzanillo2.2%

Lazaro Cardenas1.3%

Trade Statistics

Total Value$182.0M

Shipments5,454

Indian Exporters140

Mexico Buyers345

Avg Shipment$33K

Products3,360

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Mexico Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Mexico pharmaceutical trade corridor has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products valued at $211.2 million to Mexico, marking a substantial increase from previous years. This growth trajectory underscores the strengthening bilateral trade relations and India's expanding footprint in the Latin American pharmaceutical market.

Key milestones include the establishment of streamlined regulatory pathways by Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), which have facilitated faster market entry for Indian pharmaceutical companies. Additionally, strategic partnerships and collaborations between Indian exporters and Mexican distributors have bolstered the presence of Indian pharmaceutical products in Mexico.

2India's Market Position

India's pharmaceutical exports to Mexico have positioned it as a significant supplier in the Mexican market. In 2024, India exported pharmaceutical products valued at $211.2 million to Mexico, contributing to Mexico's total pharmaceutical imports of $10.08 billion in the same year. This positions India as a key player among Mexico's pharmaceutical suppliers, alongside other major exporters.

The strategic importance of this trade is evident in the diversification of India's export destinations. While the United States remains India's largest pharmaceutical export market, accounting for 35% of total exports in 2022, Mexico's growing market offers Indian pharmaceutical companies opportunities to tap into a burgeoning demand for quality medicines in Latin America.

Mexico Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Mexico must navigate COFEPRIS's regulatory framework. The Abbreviated Regulatory Pathway, effective from September 1, 2025, permits the use of prior approvals from RRAs for registration. To leverage this pathway, companies must submit a comprehensive technical dossier, including:

Proof of legal status or RUPA.
Full and reduced IPP.
Label and instruction leaflet designs.
Title, license, or sublicense for exploitation of the patent.
For foreign owners: License, certificate, or equivalent document certifying manufacturing permission from the competent authority of the country of origin.
CBPF or equivalent document for the manufacturer, issued by an ARN.
CLV or equivalent issued by the Health Authority of Origin with which equivalence is requested.
Letter of representation from the manufacturer for non-affiliated laboratories.

This streamlined process aims to expedite market entry for Indian pharmaceutical products in Mexico.

2GMP & Facility Requirements

Mexico mandates that foreign pharmaceutical manufacturers adhere to Good Manufacturing Practices (GMP) standards recognized by COFEPRIS or equivalent authorities. The inspection process involves:

Verification of compliance with GMP standards.
Assessment of manufacturing facilities to ensure product quality and safety.

Mutual recognition agreements between COFEPRIS and other regulatory bodies may facilitate the acceptance of foreign GMP certifications, potentially reducing the need for additional inspections.

3Import Documentation

Importing pharmaceutical products into Mexico requires:

Import licensing.
Certificates such as Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and GMP certificates.
Compliance with customs procedures for pharmaceutical imports.

Adhering to these requirements ensures the legal and efficient importation of pharmaceutical products into Mexico.

TransData Nexus Research · Mexico regulatory databasesMar 2026

FAQ — India to Mexico Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Mexico?

India exported pharmaceuticals worth $182.0M to Mexico across 5,454 verified shipments.

Who are the top Indian pharmaceutical exporters to Mexico?

1. ZYDUS LIFESCIENCES LIMITED — $15.8M. 2. INTAS PHARMACEUTICALS LIMITED — $14.7M. 3. GLENMARK PHARMACEUTICALS LIMITED — $12.9M. Total: 140 suppliers.

Which companies in Mexico import pharmaceuticals from India?

1. GLENMARK PHARMACEUTICALS MEXICO SA — $11.4M. 2. ZYDUS PHARMACEUTICALS M?XICO S.A. D — $8.2M. 3. MSN LIFE CARE SA DE CVRFC MLC170629 — $6.3M. 345 buyers total.

What pharmaceutical products does India export most to Mexico?

1. Mamitra(trastu Inj440mg)withdil.vialslmx ($2.7M, 1.5%); 2. Sitagliptin / Metformin Hcl 50/850mg ($2.3M, 1.2%); 3. Atcar 20mg (3x10's) Msn -mx ($1.8M, 1.0%); 4. Bhava Vialslmx(bevacizumab) ($1.7M, 0.9%); 5. Sitagliptin 100mg Tablets (2x14's) ($1.6M, 0.9%)

Which ports handle pharmaceutical shipments from India to Mexico?

Export: SAHAR AIR, DELHI AIR, HYDERABAD ICD (INSNF6), AHEMDABAD AIR ACC (INAMD4), NHAVA SHEVA SEA (INNSA1). Import: MEXICO CITY, Veracruz, VERACRUZ, Manzanillo, Lazaro Cardenas.

Why does Mexico import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $182.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Mexico?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Mexico pharmaceutical trade?

$33.4K per consignment across 5,454 shipments.

How many Indian pharmaceutical companies export to Mexico?

140 Indian companies. Largest: ZYDUS LIFESCIENCES LIMITED with $15.8M.

How can I find verified Indian pharmaceutical suppliers for Mexico?

TransData Nexus covers 140 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Mexico identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 5,454 verified shipments from 140 Indian exporters to 345 Mexico buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

140 Exporters

345 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Mexico Pharmaceutical Export

Top Pharmaceutical Formulations — India to Mexico

Top Pharmaceutical Products — India to Mexico Trade Routes

Top Indian Exporters to Mexico

Port Analysis — India to Mexico Pharmaceutical Shipments

Indian Export Ports

Mexico Import Ports

Trade Statistics

Other Destinations

India–Mexico Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top Mexico Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

Mexico Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Mexico

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Mexico

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Mexico Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Mexico for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Mexico

1Competing Origins

2India's Competitive Edge

3Challenges & Threats